Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

So-Young International Inc (SY)

  • Technical Exchange News
  • Sept. 06, 2024, 02:04 UTC
  • 48
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cadrenal Therapeutics Inc (CVKD)

  • Technical Exchange News
  • Sept. 06, 2024, 02:03 UTC
  • 48
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

So-Young International Inc (SY)

  • Technical Exchange News
  • Sept. 05, 2024, 18:50 UTC
  • 43
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cadrenal Therapeutics Inc (CVKD)

  • Technical Exchange News
  • Sept. 05, 2024, 18:49 UTC
  • 45
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

RedHill Biopharma (RDHL)

  • Technical Exchange News
  • Sept. 05, 2024, 01:53 UTC
  • 51
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Lifecore Biomedical (LFCR)

  • Technical Exchange News
  • Sept. 05, 2024, 01:53 UTC
  • 47
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Deficient.

Comment Full text

Biodexa Pharmaceuticals PLC (BDRX)

  • Technical Exchange News
  • Sept. 05, 2024, 01:53 UTC
  • 48
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

RedHill Biopharma (RDHL)

  • Technical Exchange News
  • Sept. 04, 2024, 19:27 UTC
  • 45
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Lifecore Biomedical (LFCR)

  • Technical Exchange News
  • Sept. 04, 2024, 19:27 UTC
  • 50
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Deficient.

Comment Full text

Biodexa Pharmaceuticals PLC (BDRX)

  • Technical Exchange News
  • Sept. 04, 2024, 19:26 UTC
  • 49
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 477
  • 478
  • 479
  • 480
  • 481
  • Next

Search

News categories

  • Technical Exchange News(11626)
  • Event(3890)
  • SEC News(226232)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(140478)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin